← Scroll for more →
Edgewise Therapeutics, Inc. (EWTX)
Pharmaceutical Preparations
Latest Price
$40.60
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
4.16
P/B Ratio
9.75
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 15.52M | $630.0M | 14.40% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 10.22M | $415.0M | 9.48% | +2.85M | 2026-06-30 |
| RA Capital Management, L.P. | 8.39M | $340.0M | 7.79% | -2.04M | 2026-06-30 |
| BlackRock, Inc. | 6.61M | $268.0M | 6.13% | +133.3K | 2026-06-30 |
| Jupiter Topco LLC | 6.08M | $246.0M | 5.64% | -- | 2026-06-30 |
| FMR LLC | 5.49M | $223.0M | 5.09% | +4.47M | 2026-06-30 |
| Novo Holdings A/S | 5.35M | $217.0M | 4.96% | -- | 2026-06-30 |
| Driehaus Capital Management LLC | 4.73M | $192.0M | 4.39% | +250.7K | 2026-06-30 |
| Perceptive Advisors LLC | 4.37M | $177.0M | 4.06% | -50.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.86M | $156.0M | 3.58% | +72.5K | 2026-06-30 |